These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 8265663

  • 1. Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells.
    Eaves CJ, Cashman JD, Wolpe SD, Eaves AC.
    Proc Natl Acad Sci U S A; 1993 Dec 15; 90(24):12015-9. PubMed ID: 8265663
    [Abstract] [Full Text] [Related]

  • 2. The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: evidence for an indirect mechanism.
    Cashman JD, Eaves AC, Eaves CJ.
    Blood; 1994 Sep 01; 84(5):1534-42. PubMed ID: 8068944
    [Abstract] [Full Text] [Related]

  • 3. MCP-1, not MIP-1alpha, is the endogenous chemokine that cooperates with TGF-beta to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures.
    Cashman JD, Eaves CJ, Sarris AH, Eaves AC.
    Blood; 1998 Oct 01; 92(7):2338-44. PubMed ID: 9746772
    [Abstract] [Full Text] [Related]

  • 4. Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.
    Holyoake TL, Freshney MG, Sproul AM, Richmond LJ, Alcorn MJ, Steward WP, Fitzsimons E, Dunlop DJ, Franklin IM, Pragnell IB.
    Stem Cells; 1993 Oct 01; 11 Suppl 3():122-8. PubMed ID: 8298472
    [Abstract] [Full Text] [Related]

  • 5. The biology of normal and neoplastic stem cells in CML.
    Eaves C, Udomsakdi C, Cashman J, Barnett M, Eaves A.
    Leuk Lymphoma; 1993 Oct 01; 11 Suppl 1():245-53. PubMed ID: 8251904
    [Abstract] [Full Text] [Related]

  • 6. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
    Veena P, Cornetta K, Davidson A, Agüero B, McMahel J, Traycoff CM, Srour EF.
    Bone Marrow Transplant; 1997 Jun 01; 19(12):1213-21. PubMed ID: 9208115
    [Abstract] [Full Text] [Related]

  • 7. Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-beta on normal and leukemic human hematopoietic progenitor cells.
    Cashman JD, Eaves AC, Eaves CJ.
    Leukemia; 1992 Sep 01; 6(9):886-92. PubMed ID: 1518302
    [Abstract] [Full Text] [Related]

  • 8. Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukemia progenitor cells.
    Otsuka T, Eaves CJ, Humphries RK, Hogge DE, Eaves AC.
    Leukemia; 1991 Oct 01; 5(10):861-8. PubMed ID: 1961020
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Abl protein kinase abrogates the response of multipotent haemopoietic cells to the growth inhibitor macrophage inflammatory protein-1 alpha.
    Wark G, Heyworth CM, Spooncer E, Czaplewski L, Francis JM, Dexter TM, Whetton AD.
    Oncogene; 1998 Mar 12; 16(10):1319-24. PubMed ID: 9546433
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
    Mayani H, Little MT, Dragowska W, Thornbury G, Lansdorp PM.
    Exp Hematol; 1995 May 12; 23(5):422-7. PubMed ID: 7536684
    [Abstract] [Full Text] [Related]

  • 14. Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
    Karlic H, Louda N, Pfeilstöcker M, Keil F, Lohninger A, Pittermann E, Paukovits J.
    Stem Cells; 2001 May 12; 19(4):321-8. PubMed ID: 11463952
    [Abstract] [Full Text] [Related]

  • 15. Regulatory activity of endogenous MIP-1 alpha in long-term cultures of human marrow.
    Cashman JD, Eaves AC, Wolpe S, Eaves CJ.
    Prog Clin Biol Res; 1994 May 12; 389():261-8. PubMed ID: 7700910
    [No Abstract] [Full Text] [Related]

  • 16. Macrophage inflammatory protein-1 alpha receptors are present on cells enriched for CD34 expression from patients with chronic myeloid leukemia.
    Chasty RC, Lucas GS, Owen-Lynch PJ, Pierce A, Whetton AD.
    Blood; 1995 Dec 01; 86(11):4270-7. PubMed ID: 7492787
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alpha.
    Ferrajoli A, Talpaz M, Zipf TF, Hirsch-Ginsberg C, Estey E, Wolpe SD, Estrov Z.
    Leukemia; 1994 May 01; 8(5):798-805. PubMed ID: 8182937
    [Abstract] [Full Text] [Related]

  • 18. Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth.
    Keller JR, Bartelmez SH, Sitnicka E, Ruscetti FW, Ortiz M, Gooya JM, Jacobsen SE.
    Blood; 1994 Oct 01; 84(7):2175-81. PubMed ID: 7919333
    [Abstract] [Full Text] [Related]

  • 19. Transforming growth factor beta: is it a downregulator of stem cell inhibition by macrophage inflammatory protein 1 alpha?
    Maltman J, Pragnell IB, Graham GJ.
    J Exp Med; 1993 Sep 01; 178(3):925-32. PubMed ID: 8394405
    [Abstract] [Full Text] [Related]

  • 20. Polymerization of murine macrophage inflammatory protein 1 alpha inactivates its myelosuppressive effects in vitro: the active form is a monomer.
    Mantel C, Kim YJ, Cooper S, Kwon B, Broxmeyer HE.
    Proc Natl Acad Sci U S A; 1993 Mar 15; 90(6):2232-6. PubMed ID: 8460127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.